Gd-DTPA(2-) as a measure of cartilage degradation
Gd-DTPA(2-) as a measure of cartilage degradation
复制标题
DOI:
10.1002/mrm.1910360504
复制
发表时间:
1996-11-01
影响因子:
3.3
通讯作者:
Burstein, D
中科院分区:
文献类型:
--
作者:
Bashir, A;Gray, ML;Burstein, D
Glycosaminoglycans (GAGs) are the main source of tissue fixed charge density (FCD) in cartilage, and are lost early in arthritic diseases. We tested the hypothesis that, like Na+, the charged contrast agent Gd-DTPA(2-) (and hence proton T-1) could be used to measure tissue FCD and hence GAG concentration, NMR spectroscopy studies of cartilage explants demonstrated that there was a strong correlation (r > 0.96) between proton T-1 in the presence of Gd-DTPA(2-) and tissue sodium and GAG concentrations. An ideal one-compartment electrochemical (Donnan) equilibrium model was examined as a means of quantifying FCD from Gd-DTPA(2-) concentration, yielding a value 50% less but linearly correlated with the validated method of quantifying FCD from Na+. These data could be used as the basis of an empirical model with which to quantify FCD from Gd-DTPA(2-) concentration, or a more sophisticated physical model could be developed. Spatial distributions of FCD were easily observed in T-1-weighted MRI studies of trypsin and interleukin-1 induced cartilage degradation, with good histological correlation. Therefore, equilibration of the tissue in Gd-DTPA(2-) gives us the opportunity to directly image (through T-1 weighting) the concentration of GAG, a major and critically important macromolecule in cartilage. Pilot clinical studies demonstrated Gd-DTPA(2-) penetration into cartilage, suggesting that this technique is clinically feasible.